BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Sulforaphane {Dark Greens} - Turicibacter |
📓
Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS. AMB Express (AMB Express ) Vol: 10 Issue 1 Pages: 119 Pub: 2020 Jul 3 Epub: 2020 Jul 3 Authors Zhang Y , Tan L , Li C , Wu H , Ran D , Zhang Z , Publication |
| Sulforaphane {Dark Greens} - Turicibacter |
📓
Broccoli seed extract rich in polysaccharides and glucoraphanin ameliorates DSS-induced colitis via intestinal barrier protection and gut microbiota modulation in mice. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 103 Issue 4 Pages: 1749-1760 Pub: 2023 Mar 15 Epub: 2022 Dec 24 Authors Wu J , Guo W , Cui S , Tang X , Zhang Q , Lu W , Jin Y , Zhao J , Mao B , Chen W , Publication |
| Sulforaphane {Dark Greens} - Turicibacter |
📓
Combined Phytochemical Sulforaphane and Dietary Fiber Inulin Contribute to the Prevention of ER-Negative Breast Cancer via PI3K/AKT/MTOR Pathway and Modulating Gut Microbial Composition. Nutrients (Nutrients ) Vol: 17 Issue 12 Pages: Pub: 2025 Jun 17 Epub: 2025 Jun 17 Authors Wu H , Witt BL , van der Pol WJ , Morrow CD , Duck LW , Tollefsbol TO , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
